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Abstract
Background: Hip osteoarthritis (hip OA) is a disease with a major impact on both national economy and the
patients themselves. Patients suffer from pain and functional impairment in activities of daily life which are
associated with a decrease in quality of life. Conservative therapeutic interventions such as physical exercises aim at
reducing pain and increasing function and health-related quality of life. However, there is only silver level evidence
for efficacy of land-based physical exercise in the treatment of hip OA. The purpose of this randomized controlled
trial is to determine whether the specific 12-week exercise regime “Hip School” can decrease bodily pain and
improve physical function and life quality in subjects with hip osteoarthritis.
Methods/Design: 217 participants with hip OA, confirmed using the clinical score of the American College of
Rheumatology, are recruited from the community and randomly allocated to one of the following groups: (1)
exercise regime “Hip School”, n = 70; (2) Non-intervention control group, n = 70; (3) “Sham” ultrasound group, n =
70; (4) Ultrasound group, n = 7. The exercise regime combines group exercises (1/week, 60-90’) and home-based
exercises (2/week, 30-40’). Sham ultrasound and ultrasound are given once a week, 15’. Measures are taken directly
prior to (M1) and after (M2) the 12-week intervention period. Two follow-ups are conducted by phone 16 and 40
weeks after the intervention period. The primary outcome measure is the change in the subscale bodily pain of the
SF36 from M1 to M2. Secondary outcomes comprise the WOMAC score, SF36, isometric strength of hip muscles,
spatial-temporal and discrete measures derived from clinical gait analysis, and the length of the centre of force
path in different standing tasks. An intension-to-treat analysis will be performed using multivariate statistics (group
× time).
Discussion: Results from this trial will contribute to the evidence regarding the effect of a hip-specific exercise
regime on physical function, pain, and health-related quality of life in patients with hip osteoarthritis.
Trial registration: German Clinical Trial Register DRKS00000651.
Background
Prevalence and treatment modalities of osteoarthritis
Osteoarthritis (OA) is a disease with a major impact on
both the national economy and the patients themselves.
In Germany, approximately five million people suffer
from osteoarthritis [1]. It is the most prevalent muscu-
loskeletal disease and its impact on morbidity and
mortality in industrialized countries is almost as large as
the impact of respiratory or digestive disorders [2]. The
knee and hip joints are the most commonly affected
joints of this disease [1,3]. Data from a large cohort-
study reveal hip symptoms in 36% of an American
population aged 45 and older. 28% of this population
had radiographic, and 10% had symptomatic hip OA [4].
Prevalence for symptomatic hip OA increases in older
individuals and women [4]. According to demographic
estimates, more than 20% of the population will be
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will further increase. Patients suffer from pain and func-
tional impairment in activities of daily life such as walk-
ing or climbing stairs [6,7]. Strength deficits and gait
disturbances like gait asymmetries and reduced walking
speed are frequent findings [8-10]. Bodily pain and defi-
cits in physical functioning are associated with a
decrease of life quality [7,11].
Joint replacement is the treatment strategy in the final
stages of hip or knee OA. In earlier stages, conservative
therapeutic interventions are important to reduce pain
and increase function and health-related quality of life
[12]. In this respect, physical therapy and physical exer-
cise programs are relevant and important therapeutic
options. Here, treatments during which the patient is
active are preferable to passive therapies [13,14]. Physi-
cal exercises in particular are non-hazardous in terms of
side-effects and can have positive effects on life quality,
management of everyday life and physical functioning
[15-19]. Exercises can further decrease pain and their
efficacy was shown to be comparable to the efficacy of
non-steroidal anti-inflammatory drugs (NSAIDs). In
addition, they do not have expected adverse reactions in
comparison to the long term use of NSAIDs [14,20].
Evidence for effectiveness of exercises in the treatment of
lower limb osteoarthritis
Platinum/1a level of evidence is given for the efficacy of
joint related exercise programs with respect to pain
reduction and increase of function in subjects with knee
OA. It applies to analyses including data of aquatic and
land-based exercises, as well as for land-based exercises
only [21,22]. According to the EULAR evidence based
recommendations for the management of hip osteoar-
thritis published in 2004, data on exercise interventions
for hip OA are required to determine the benefit of
treatments at each key site of OA, as there may be true
treatment differences for OA according to the site
affected [23]. More recently, meta-analyses have been
published focusing explicitly on the effects of exercise
on hip osteoarthritis. Combined data of aquatic and
land-based exercises for hip OA demonstrate evidence
(1a) for the reduction in pain [24,25]. However, there is
only silver-level evidence for the efficacy of land-based
physical exercise to reduce pain and to improve function
in the treatment of hip OA [26]. The aforementioned
review summarizes the effects of only five randomized
controlled trials (RCTs) which were included into the
meta-analysis. Only one of these studies explicitly
focused on patients with hip osteoarthritis. The authors
conclude that the limited number and small sample size
of the included RCTs restricts the confidence that can
be attributed to the presented results. Therefore,
adequately powered RCTs evaluating exercise programs
specifically designed for people with symptomatic hip
OA need to be conducted [26].
Aside from a lack of large RCTs studies on subjects
with hip OA, there is not much known about how an
optimised training program should be designed and
what kind of training would be the most efficient for
treating hip and knee OA [19,27,28].
Hip School
The group exercise program “Hip School” was estab-
lished in 1996 [29,30]. Since then, more than 20 therapy
groups have been organized in the region allowing many
patients with hip osteoarthritis access to a supervised
training program. Several studies were conducted pre-
viously to evaluate the efficacy of the Hip School
[31-34]. However, its efficacy has not yet been demon-
strated in a randomised controlled trial using generally
accepted measures. This lack of evidence is being
addressed by the clinical trial described in this study
protocol. The protocol is based on (a) previous pilot
studies investigating the reliability, validity, and feasibil-
ity of the methods that will now be used to quantify effi-
cacy outcomes in subjects with hip osteoarthritis
[35-37], and (b) an interventional study used to quantify
efficacy and feasibility of an additional home-based exer-
cise program in combination with the aforementioned
therapy regime [38-40].
Study purpose
The primary aim of this study is to determine whether a
12-week intervention program comprising group and
home-based exercises decreases bodily pain in subjects
with hip osteoarthritis in comparison to a non-treated
control group. Efficacy is quantified by the subscale bod-
ily pain of the SF36. The secondary aim is to determine
whether this exercise regime can improve function,
health-related quality of life, strength of hip surrounding
muscles, postural control in bi-pedaled, tandem-, and
single leg stance, joint function, and gait parameters in
comparison to a non-treated control group, an attention
control group (sham ultrasound), and an ultrasound
group. Ultrasound therapy is only investigated in an
explorative manner. Follow-up data are recorded to
evaluate the sustainability of the interventional programs
over another 40 weeks.
It is hypothesized that a 12-week intervention pro-
gram will (1) decrease pain, and (2) improve physical
function in comparison to a non-treated control. It is
further hypothesized that (3) the efficacy of the exercise
regime is superior to the efficacy of an intervention
solely aiming for attention control, and (4) that effects
are long-acting.
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Design
This is a randomized, controlled trial, single-blinded for
participants for two of the four treatment options (sham
ultrasound and ultrasound) (Figure 1). Recruited
patients undergo telephone screening followed by a clin-
ical examination by a medical doctor to ensure eligibil-
ity. Eligible participants then undergo outcome
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Figure 1 Trial protocol.
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Page 3 of 12assessment using the complete test battery prior to
intervention, and will subsequently be randomized to
one of the four groups. A ratio of 10:10:10:1 will be
used for randomization into Hip School (HS), no inter-
vention group (CO), sham ultrasound group (SUS), and
ultrasound group (US). During the 12 week intervention
period, monthly logbooks for physical exercises and pain
have to be completed by all subjects. The complete test
battery is repeated after the 12 week interventional per-
iod. Questionnaires (WOMAC, SF36) and log books are
accessed via telephone assessment 16 and 40 weeks after
the retest.
Randomization process and allocation concealment
Randomization is stratified by gender due to its possible
influence on efficacy of strengthening exercises [41,42].
Since not all subjects can be measured and treated
simultaneously, the study is divided into four identical
interventional periods (sequence 1-4), and the men-
tioned allocation procedure is performed in permuted
blocks of 50-60 subjects each. The randomization
sequence is generated electronically prior to each inter-
ventional period. Participants draw a lot with a rando-
mization number at the beginning of baseline
assessment. This process is double-blinded (participant
and investigator). At the end of the baseline assessment,
a study nurse compares the randomization number of
the lot with the randomization list displaying informa-
tion on treatment allocation. Group allocation is then
documented on an extra sheet of the case report form.
The case report form is filed after baseline assessment.
The assignment process as described prevents foreknow-
ledge of treatment assignment.
Blinding
Treatment allocation to ultrasound and sham-ultra-
sound is blinded to the subject. Blinding of the investi-
gator is not possible as sham-ultrasound is applied
according to the normal routine without turning on the
power.
Day and Altman suggest blinding assessment by using
non-involved assessors to record outcome variables [43].
However this is not feasible in the context of the given
study. To allow readers to judge possible information
bias, assessment routine and blinding are stated expli-
citly [44]. Blinding is impossible as treatment exposure
can be discovered by interviewing the study participants
(except the differentiation between US and SUS, which
is kept single-blinded until the end of the study).
Furthermore, independent assessors are not available, as
quantification of outcomes needs specific know-how
and man-power of our institution is limited. Moreover,
instrumented gait analysis and assessment of postural
control using pressure mats are relatively objective
measures with limited possibility of exerting external
influence. Strength measures may be more susceptible
to external influences, as motivation is an important fac-
tor for maximum strength development. To minimize
potential influence of the assessors, instructions are
standardized and always given by the same investigator.
SF36 and WOMAC are self-administered psychometric
instruments. Subjects are introduced to the question-
naires at the beginning of the baseline assessment before
treatment allocation is done. Subjects may contact the
study nurse in case of questions. However, there is no
assessor recording the responses of the subjects to the
questionnaires and therefore no need for blinding.
Participants
217 men and women aged between 18 and 85 years are
recruited via regional press, flyers in medical and phy-
siotherapeutic practices, the outpatient clinic of the
Department of Sports Medicine, and personal communi-
cation. Eligibility is confirmed by verbal and clinical
examination carried out by the principal investigator of
the study (medical doctor). Criteria for hip osteoarthritis
are defined according to the clinical criteria of the
American College of Rheumatology [45]. Other inclu-
sion criteria are: (i) health-related eligibility in terms of
physical and mental ability to participate in the inter-
ventional program; (ii) sufficient time to keep therapeu-
tic appointments; (iii) capacity to consent. Annotation:
Subjects can also be included in the case of a contra-lat-
eral hip replacement, as long as one side has a hip
osteoarthritis according to the above mentioned criteria.
Exclusion criteria are: (i) instable anchoring of an arti-
ficial hip replacement; (ii) luxation as an adverse event
of artificial hip replacement; (iii) predominant knee OA;
(iv) pathologies in the region of the lower extremities or
lower back that are not related to OA and need medical
treatment; (v) inability to ambulate without walking
aids; (vi) hip joint injections within the last 3 months;
(vii) surgery at the lower extremity within the last 3
months; (viii) previous trauma at the hip or pelvis with
subsequent development of a secondary arthrosis; (vix)
known endocrinological cause of hip OA (hyperuricae-
mia, hyperparathyroidism, hyperuricaemia); (x) verified
metabolic cause of hip OA (haemochromatosis, rachitis,
chondrocalcinosis, ochronosis); (xi) state after aseptic
osteonecrosis (Perthes’ disease); (xii) neurological disease
leading to sensomotoric deficits; (xiii) cardio-vascular
disease or other co-morbidities resulting in a profoundly
decreased physical capacity in everyday life and that are
known as contraindications for physical activities (i.e.
cardiac insufficiency NYHA III-IV, terminal renal insuf-
ficiency); (xiv) medical exercise therapy or physiotherapy
using weight machines and comparable resources during
t h el a s t3m o n t h sa n dc a r r i e do u ta tl e a s t6t i m e s ;( x v )
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OA in the last 3 months (minimum 1x/week, 30 min-
utes or more); (xvi) physical therapy to address hip OA
(minimum 1x/week); (xvii) novel initiated physical exer-
cise within the last 3 months (minimum 1x/week to be
short of breath for at least 30 minutes); (xviii) abuse of
drugs or alcohol; (xix) participation in another clinical
trial in the last four weeks; (xx) no compliance; (xxi)
acute illness.
Ethical approval has been obtained from the Ethics
Committee of the University of Tuebingen (358/
2010BO2). All participants will provide written informed
consent.
Interventions
All participants are requested to refrain from seeking
other forms of treatment during the 12 week-interven-
tion period from M1 to M2. Subsequently, subjects are
offered to participate in the intervention group they
were not allocated to before for another 12 weeks.
Many studies compare exercise interventions with an
untreated control group (parallel group design or wait-
ing list design) [26,46]. However it is well known that a
placebo is significantly superior to the effect of
untreated controls [47]. The used study design will help
to distinguish between treatment effects of physical
exercise, attention control (sham ultrasound), and unac-
companied study participation (no intervention group).
Hip School(HS)
The Hip School program is a comprehensive, pre-
defined 12-week training program. Not all exercises can
be displayed in detail as this would be beyond the scope
of this study protocol. However, some details are listed
below to allow an opinion to be made on relevant issues
of the training program.
The Hip School comprises group (1x/week, 60-90’)
and home based exercises (2x/week, 30-40’). Group size
is restricted to a maximum of 15 participants. Elastic
rubber bands, stability trainers (pads), exercise balls and
exercise mats are used as training devices. Group and
home training sessions include hip specific elements of
motor learning and mobilization, strength training and
exercises to improve postural control, as specified
below. Group sessions further include education related
to exercises, such as information on anatomical basics
and training modalities. The sessions enhance social
contacts by having group-based introductions and feed-
backs before and after the exercises, and by enforcing
partner and group exercises. In the group lessons, sub-
jects are introduced to the exercises they have to do at
home. In addition, subjects receive exercise leaflets with
pictures of the exercises and written instructions every
week.Detailed description of group and home-based
training modalities:
Mobility exercises include elements to increase flex-
ibility of the lumbar spine, pelvis and hip joints. An
example for sagittal plane motion is given in Figure 2.
Muscle stretching mainly addresses hip and knee flexors
and extensors and hip adductors. Perception skills are
trained to allow proper exercise execution, and to
enhance motor control.
Strength training comprises open and closed kine-
matic chain exercises for extensors, flexors, abductors
and adductors of the hip, as well as flexors and exten-
sors of the knee. Examples for open and closed kine-
matic chain exercises for hip extensors are given in
Figures 3 and 4. Intensity and structure of the exercises
follow a progressive concept (Table 1) and are moni-
tored using a Borg Scale.
Leg-alignment training is included in all exercises for
postural control. These exercises also follow a progres-
sive training concept, as displayed in Figure 5 for static
conditions. Week 9-12 includes further dynamic
exercises.
No intervention group (CO)
Subjects allocated to this group do not receive any ther-
apeutic intervention between M1 and M2. They are
requested to continue their usual routine.
Sham ultrasound (SUS)
Frequency, duration, and total number of treatments for
sham ultrasound are equivalent to the procedure
described for ultrasound. However, intensity is turned off.
Ultrasound (US)
Despite low quality of given evidence, therapeutic ultra-
sound may be beneficial for patients with osteoarthritis
of the knee [48]. In subjects with hip OA, ultrasound in
addition to standard physiotherapy has been shown to
be superior in terms of a longitudinal positive effect on
pain, functional status, and physical quality of life in
comparison to a standard physiotherapy with and with-
out sham ultrasound [49]. Safety of this intervention has
yet not been disproved, and to date no serious adverse
events have been reported [48]. In the context of this
study, ultrasound is used as a comparable verum inter-
vention to sham ultrasound (SUS). It would be unethical
to include SUS only, as subjects are told that they may
receive real ultrasound or sham ultrasound. US will be
applied in a minor number of subjects, serving to
explore its potential benefits in the treatment of hip OA
in a different dosage as investigated before [49]. Ultra-
sound is applied with a commercially available ultra-
sound apparatus (Zimmer MedizinSysteme GmbH,
Germany). Instrument adjustments and treatment mod-
alities are presented in Table 2.
Outcome measures (Figure 1)
Participants are assessed at baseline (M1), and 12 weeks
after the intervention period (M2). Patient
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at the baseline assessment. Questionnaires (WOMAC,
SF36), measures of postural control, clinical gait analy-
sis, functional tests (passive range of motion (ROM),
muscle flexibility), and isometric strength measures are
evaluated at M1 and M2. Previous physiotherapy and/or
exercises, medication, and pain (retrospective time
frame of four weeks) are evaluated at M1 and noted
each subsequent month up to M2 in a logbook. Satisfac-
tion with the therapy regime is assessed with a question-
n a i r ea tM 2a n dM 3 .1 6w e e k sp a s tM 2( M 3 )a n d2 4
weeks past M3 (M4), participants are contacted again
via telephone to assess WOMAC, SF36, previous phy-
siotherapy and/or exercises, and medication.
Questionnaires
The 36-item Short Form (SF36) is a well-established
generic health status measure and allows the effect of an
OA intervention to be gauged in comparison with other
interventions [50]. It comprises different scales, four of
them related to physical health (physical functioning,
role-physical, bodily pain, general health), and four of
them related to mental health (vitality, social function-
ing, role-emotional, mental health). The primary
outcome measure of this study is the subscale bodily
pain of the SF36. The other scales and sum scores will
also be analysed as secondary outcomes.
The Western Ontario McMasters Universities
Osteoarthritis Index (WOMAC
® NRS German for Ger-
many 3.1 Index) is a disease-specific instrument used to
evaluate self-reported pain, stiffness and functional
impairment. It is a valid, reliable and responsive score,
easy to complete, simple to score and available in multi-
ple language forms and scaling formats [51].
A five point Likert Scale is used on M2 and M3 to
quantify satisfaction with the therapy regime, and
whether participants would recommend this therapy to
others.
Level of education of the subjects is recorded to con-
trol for a recruiting bias.
Monthly logbooks
Participants are asked to fill out a monthly logbook
between M1 and M2. They have to specify previous
physiotherapy and/or exercise, medication, and pain
(retrospective time frame of four weeks). This informa-
tion is also requested on M3 and M4 in the context of
the telephone call.
Figure 2 Mobilisation exercise. Example of an exercise for lumbar spine, pelvis and hip joint mobilisation.
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Postural control is quantified in bi-pedaled, tandem-,
and single leg stance on a measuring system for force
distribution (FDM System, zebris Medical GmbH, Isny,
Germany). The outcome measure for postural control is
the total path of the centre of force over the entire trial.
Subjects are allowed to familiarize themselves with each
mode prior to recording. Modalities of the different
Figure 3 Strength training for hip and knee extensors. Example of an exercise for closed kinematic chain training.
Figure 4 Strength training for hip extensors. Example of an exercise for open kinematic chain training.
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Trials of each mode are averaged prior to further
analysis.
Clinical gait analysis
Participants undergo three-dimensional gait analysis in
barefoot and shod conditions at self-selected normal
speed that is monitored by light-barriers. After two sta-
tic trials, participants continuously walk back and forth
on an eleven meter walk-way until at least seven valid
trials for each side and condition are captured. For the
barefoot condition, the walk-way is covered with an
EVA-foam (shore 80) to allow a comfortable and natural
walking pattern. Kinematic and spatial-temporal data are
collected using a Vicon motion analysis system with six
cameras (ViconPeak, MCAM M1, 120 Hz, Oxford, UK).
Data are analysed with the lower body model of the
conventional gait model Plug-in-Gait (Vicon Polygon,
Oxford Metrics Ltd., Oxford, UK). Markers are placed
on the superior and posterior iliac spines, lateral thigh,
and lateral epicondyle of the knee, lateral shank, lateral
malleolus, calcaneus, and second metatarsal head. Addi-
tional markers are placed on the toe or toe cap, respec-
tively, to ease the detection of toe off.
Outcome measures include the following spatial-tem-
poral variables: stride length, step length, step width,
walking velocity, cadence, single and double support
time. Other variables of interest include time histories,
maximum and minimum joint angles, and ranges of
motion of the sagittal plane for pelvis, hip, knee, and
ankle joint, as well as pelvic drop and hip adduction and
Table 1 Training progression for strength exercises.
Week Objective Intensity (% max strength) Repetitions/Sets
1-3 Motor learning < 30% ≥ 30/1
4-8 Strength endurance 30-40% 20-25/2-3
9-12 Endurance & maximum strength 40-70% 10-15/3-4
Figure 5 Progressive training concept. Procedural method for static exercises of postural control.
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five trials for each limb and condition (barefoot and
shod) are extracted and averaged with a customized
Matlab routine (Mathworks Inc., Natick, Massachusetts,
USA).
Functional tests
Pelvic obliquity, passive ranges of motion of the hip,
knee and ankle joint and muscular flexibility of the
iliopsoas muscle, rectus femoris muscle and the ham-
strings are examined by a physiotherapist.
Isometric strength measures
The Isomed 2000 (D&R GmbH, Hernau, Germany) iso-
kinetic dynamometer is used to measure isometric peak
torque for hip abduction (HAB), hip adduction (HAD),
hip flexion (HF) and hip extension (HE). The feasibility
and reliability of the test protocol was evaluated in a
previous study. It was shown, that HAD and HE are
prone to larger measurement errors. This can be
explained by a hindered fixation, as the pelvis is pried
upwards when the leg pushes downwards [37]. For this
reason, tests are accompanied by two investigators to
ensure proper fixation and to decrease the time
necessary per measurement and ensuring a high level of
standardization with respect to the test procedure.
While one investigator operates the device and give
standardized instructions to each subject, another inves-
tigator manually stabilize the subject’sp e l v i sd u r i n ga l l
measurements of HAD and HE, where the pelvis tends
to become instable. This investigator further monitors
the subjects during the measurements for signs of pain
or muscle cramps.
Test procedure: Subjects accomplish a five minute
warm-up on a bicycle ergometer (50-100 Watt) followed
by some stretching exercises. Subsequently, the randomly
selected starting leg is allotted and subjects remove their
shoes. Prior to the test, a knee orthosis is attached to the
tested leg. For HAB and HAD, the orthosis is set at 90° at
the knee. For HF and HE, the orthosis is set at 0°. The
orthosis is necessary to decrease measurement artifacts
related to oscillations and resulting moments of inertia of
the shank and foot. All test modes are performed on each
leg separately. Test mode and sequence, subject position-
ing, joint angle position and annotations for fixation are
given in Table 4. Maximal axis-joint alignment is insured
before subjects are fixed to the surface and dynamometer.
Each trial is initialised by a sub-maximum test trial to
allow participants to get used to the work movement and
measurement procedure. Participants are then asked to
contract their muscles to the maximum three times in a
given time frame of 40 seconds against the fixed lever arm
of the dynamometer. Each test trial is followed by a break
of 30 seconds. After all strength tests, a physiotherapist
performs some traction and stretching exercises to allow
relaxation of joints and muscles of the participants.
Proposed sample size/power calculation
The primary endpoint is the change of SF36: Subscale
bodily pain from M1 to M2 of HS in comparison to
Table 2 Instrument adjustments and treatment
modalities for ultrasound therapy
Parameter Setup
Frequency 1 MHz
Mode Continuous mode
Intensity 1 W/cm
2
Head size 5c m
2
Duration of treatment 15’ (5’ each from anterior, lateral, and
posterior)
Treatment area 70-80 cm
2 about the affected hip joint
Treatment frequency 1/week
Total number of
treatments
12
Table 3 Test modalities for postural control
Test Position Recording time Number of trials
Bi-pedaled with eyes open Feet in parallel position
Weight is equally distributed on the feet
Knees slightly bended
Arms akimbo
10 s each 3 each
Bi-pedaled with eyes closed
Tandem stance right foot in front Feet are placed on a line, one before the other
Toes of the rear foot are in contact with the heel of the leading foot
Weight is equally distributed on both feet
Knees are slightly bended
Arms akimbo
6 s each 3 each
Tandem stance left foot in front
Single-led stance right Single led stance
Knee of the supporting leg is slightly bended
Non-supporting leg is not allowed to touch supporting leg
Arms akimbo
6 s each 5 each
Single-led stance left
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pain scale of the disease specific WOMAC in patients
with osteoarthritis undergoing a rehabilitation interven-
tion [52]. The SF36 is recommended as a generic instru-
ment for recording relevant domains in osteoarthritis of
the lower limb [53]. It is the most widely used generic
health instrument [52] and allows comparison of disease
states within and between different disorders.
Sample size calculation is based on clinically relevant
changes: An effect smaller than the minimum clinical
important difference (MCID) may be measureable
although patients will be unable to notice it [50]. MCID
was derived from literature [50], basic values and statis-
tical spread of the measure for the given population
were derived from a pilot study of our own research
group on subjects with hip osteoarthritis. According to
the mentioned presumptions, a sample size of n = 60 in
each group will have 80% power to detect a clinically
relevant difference in bodily pain for HS in comparison
to CO using a two group t-test with a 0.05 two-side sig-
nificance level. A failure rate of 15-20% is approximated,
thus final sample size is set at n = 70 for each group,
except US with n = 7. This is only an explorative inter-
vention. Sample size was calculated using G*Power Ver-
sion 3.0.10 (Franz Faul, Universitaet Kiel, Germany).
Statistical analysis
Data will be analyzed on an intention-to-treat principle
using all randomized participants. Missing data will be
filled in by carrying the last score forward. A per proto-
col analysis will also be conducted as a subordinate type
of analysis. Demographic characteristics, joint and mus-
cle function, and logbooks will be displayed with
descriptive statistics. Multivariate statistics will be used
(factors: group × time) for outcomes measured on a
continuous scale. For strength measures, baseline levels
will be included as covariates.
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